Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice

Journal of Lipid Research

Volumn 49, Issue 8, 2008, Pages 1640-1645

  Wang, Yunlong ^a   Zhu, Xuewei ^a   Wu, Gang ^a   Shen, Le ^a   Chen, Baosheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apolipoprotein A I; Cysteine mutant; Inflammatory cytokines; Lung injury; RHDL

Indexed keywords

ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN A1; CYSTEINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MUTANT PROTEIN; RECOMBINANT HIGH DENSITY LIPOPROTEIN 107; RECOMBINANT HIGH DENSITY LIPOPROTEIN 129; RECOMBINANT HIGH DENSITY LIPOPROTEIN 173; RECOMBINANT HIGH DENSITY LIPOPROTEIN 195; RECOMBINANT HIGH DENSITY LIPOPROTEIN 228; RECOMBINANT HIGH DENSITY LIPOPROTEIN 52; RECOMBINANT HIGH DENSITY LIPOPROTEIN 74; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOTOXEMIA; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; LUNG; PATHOLOGY; ULTRASTRUCTURE;

AMINO ACID SUBSTITUTION; ANIMALS; APOLIPOPROTEIN A-I; CYSTEINE; ENDOTOXEMIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MICE; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51449103650     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700446-JLR200     Document Type: Article

References (32)

1. Gunn, J. S., and R. K. Ernst. 2007. The structure and function of Francisella LPS. Ann. N. Y. Acad. Sci. 1105: 202-218.
2. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90: 12040-12044.
3. Romeo, D., A. Hinckley, and L. Rothfield. 1970. Reconstitution of a functional membrane enzyme system in a monomolecular film. II. Formation of a functional ternary film of lipopolysaccharide, phospholipid and transferase enzyme. J. Mol. Biol. 53: 491-501.
4. Weiser, M. M., and L. Rothfield. 1968. The reassociation of lipopolysaccharide, phospholipid, and transferase enzymes of the bacterial cell envelope. Isolation of binary and ternary complexes. J. Biol. Chem. 243: 1320-1328.
5. Schumann, R. R., S. R. Leong, G.W. Flaggs, P.W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science. 249: 1429-1431.
6. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229: 869-871.
7. Vesy, C. J., R. L. Kitchens, G. Wolfbauer, J. J. Albers, and R. S. Munford. 2000. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68: 2410-2417.
8. Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharideinduced signal transduction. J. Biol. Chem. 274: 10689-10692.
9. Emancipator, K., G. Csako, and R. J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60: 596-601.
10. Flegel, W. A., A. Wolpl, D. N. Mannel, and H. Northoff. 1989. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect. Immun. 57: 2237-2245.
11. Read, T. E., H. W. Harris, C. Grunfeld, K. R. Feingold, J. P. Kane, and J. H. Rapp. 1993. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur. Heart J. 14: 125-129.
12. Baumberger, C., R. J. Ulevitch, and J. M. Dayer. 1991. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology. 59: 378-383.
13. Chan, L. 1989. The apolipoprotein multigene family: structure, expression, evolution, and molecular genetics. Klin. Wochenschr. 67: 225-237.
14. Thomas, M. J., S. Bhat, and M. G. Sorci-Thomas. 2006. The use of chemical cross-linking and mass spectrometry to elucidate the tertiary conformation of lipid-bound apolipoprotein A-I. Curr. Opin. Lipidol. 17: 214-220.
15. Segrest, J. P., D. W. Garber, C. G. Brouillette, S. C. Harvey, and G. M. Anantharamaiah. 1994. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Protein Chem. 45: 303-369.
16. Zhu, X., G. Wu, W. Zeng, H. Xue, and B. Chen. 2005. Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties. J. Lipid Res. 46: 1303-1311.
17. Reichelt, P., C. Schwarz, and M. Donzeau. 2006. Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expr. Purif. 46: 483-488.
18. Bordier, C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256: 1604-1607.
19. Liu, S., R. Tobias, S. McClure, G. Styba, Q. Shi, and G. Jackowski. 1997. Removal of endotoxin from recombinant protein preparations. Clin. Biochem. 30: 455-463.
20. Chen, C.H., and J. J. Albers. 1982. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J. Lipid Res. 23: 680-691.
21. Yan, Y. J., Y. Li, B. Lou, and M. P. Wu. 2006. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice. Life Sci. 79: 210-215.
22. Bhat, S., M. G. Sorci-Thomas, E. T. Alexander, M. P. Samuel, and M. J. Thomas. 2005. Intermolecular contact between globular Nterminal fold and C-terminal domain of apoA-I stabilizes its lipidbound conformation: studies employing chemical cross-linking and mass spectrometry. J. Biol. Chem. 280: 33015-33025.
23. McDonald, M. C., P. Dhadly, G. W. Cockerill, S. Cuzzocrea, H. Mota-Filipe, C. J. Hinds, N. E. Miller, and C. Thiemermann. 2003. Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock. Shock. 20: 551-557.
24. Lee, R. P., N. T. Lin, Y. F. Chao, C. C. Lin, H. J. Harn, and H. I. Chen. 2007. High-density lipoprotein prevents organ damage in endotoxemia. Res. Nurs. Health. 30: 250-260.
25. Hubsch, A. P., A. T. Casas, and J. E. Doran. 1995. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models. J. Lab. Clin. Med. 126: 548-558.
26. Rall, D. P., J. R. Gaskins, and M. G. Kelly. 1957. Reduction of febrile response to bacterial polysaccharide following incubation with serum. Am. J. Physiol. 188: 559-562.
27. Ulevitch, R. J., and A. R. Johnston. 1978. The modification of biophysical andendotoxic properties of bacterial lipopolysaccharides by serum. J. Clin. Invest. 62: 1313-1324.
28. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1979. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J. Clin. Invest. 64: 1516-1524.
29. Murch, O., M. Collin, C. J. Hinds, and C. Thiemermann. 2007. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med. 33: 13-24.
30. Grunfeld, C., M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold. 1999. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252.
31. Harris, H. W., C. Grunfeld, K. R. Feingold, and J. H. Rapp. 1990. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86: 696-702.
32. Cué, J. I., J. T. DiPiro, L. J. Brunner, J. E. Doran, M. E. Blankenship, A. R. Mansberger, and M. L. Hawkins. 1994. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits. Arch. Surg. 129: 193-197.